Virtuix Holdings Inc

CEO Jan Roger’s recent bulk sale of 20,279 Virtuix shares sparks debate over the company’s defense‑training push and stock volatility.

CEO Jan Roger Goetgeluk’s rapid Rule 10b5‑1 sales cut Virtuix holdings by almost $250k—what this means for investor confidence and future prospects.

CEO Jan Goetgeluk’s recent 130k+ share sales at Virtuix Holdings raise concerns, yet are part of a planned liquidity strategy—watch the May 8 investor webinar for signs of recovery.

CEO of Virtuix Holdings sells 300k+ shares in April 10‑b‑5‑1 plan, driving 78% YTD price drop—investors must weigh liquidity needs vs company fundamentals.

Insider selling by Virtuix CEO shows a routine, disciplined trade plan; investors should watch cumulative sales and future filings for potential market impact.

CEO Rule 10b5‑1 sales at Virtuix Holdings reveal insider selling amid a steep 74 % price drop and a pivot to medical and defense markets. Insights for investors.

CEO of Virtuix sells shares at peak, raising insider confidence questions—what does this mean for investors and long‑term prospects?

CEO Jan Roger’s 10b5‑1 sales of Virtuix shares show portfolio rebalancing, not a confidence drop—watch upcoming defense‑tech news for real moves.

Virtuix insider confidence: key execs hold & buy shares amid a 72% plunge, signaling belief in defense pivot and potential rebound—watch earnings & contracts for clues.